USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cousin Biotech

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cousin ranks #26,063 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#26,063
of 49,997 US assignees by volume
22nd percentile
by Innovation Score (27.0/100)
16.8
avg claims per patent
-57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26063 · Foreign Corporation #26,063 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,063/49,997
  • PHOTO-FINISH Corners
  • CPC-NARROW A61B · 6 areas
  • INNOV-THIN 27.0/100
  • CLAIMS-RICH 16.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -57% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Corners, Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cousin’s 27.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cousin

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cousin's Innovation Score is 27.0/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cousin?

Each dot is one of Cousin’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cousin’s own 16.8 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cousin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 51015202530 Granted patents (volume) Avg claims / patent Corners, Co., Ltd. - 10, 10.6CornersCorning Gilbert, Inc. - 10, 19.7Corning GilbertCosentino Research & Development S.L. - 10, 17.2Cosentino Researc…Cosmecca Korea Co., Ltd. - 10, 12.2Cosmecca KoreaCP Kelco ApS - 10, 23.5CP Kelco ApsCR Development AB - 10, 15.1CR Development ABCRC R&D, LLC - 10, 25.2CRC R&DCreating Nano Technologies, Inc. - 10, 12.3Creating NanoCousin Biotech - 10, 16.8Cousin Biotech
Cousin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cousin's grants concentrate

Cousin Biotech is a focused PatentsView assignee: 6 CPC subclasses with 90% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2017. By volume, Cousin sits between Corners, Co., Ltd. and Creating Nano Technologies, Inc..

Who files at Cousin's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cousin holds 10 patents at rank #25,999, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cousin

By rank, the assignees closest to #25,999 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Cousin's primary technology class.

Cousin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152017201820192020 3
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cousin Biotech patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 20.0%
2017 1 10.0%
2018 2 20.0%
2019 2 20.0%
2020 3 30.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cousin Biotech's patent record in context - here's where to go next.

  • Cousin Biotech's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 90% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #26,063 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cousin Biotech against Corners, Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.